![](https://i0.wp.com/osseotech.com/wp-content/uploads/2018/03/1297441631AstratechForSale.jpg?fit=300%2C220&ssl=1)
AstraZeneca is considering spinning off a Swedish business that makes dental implants and medical devices for $2bn (£1.25bn). The Anglo-Swedish drugmaker said today that it had hired JP Morgan Chase to help with a strategic review of the firm. In 2009 the industry suffered its weakest year, with sales falling by 3% to 5%. This year the market has been flat but it is slowly recovering. Potential suitors for Astra Tech include US rivals such as privately held Biomet, along